116 related articles for article (PubMed ID: 9005146)
41. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer.
Adachi Y; Itoh F; Yamamoto H; Arimura Y; Kikkawa-Okabe Y; Miyazaki K; Carbone DP; Imai K
Int J Cancer; 2001 Jul; 95(4):216-22. PubMed ID: 11400113
[TBL] [Abstract][Full Text] [Related]
42. Transfusion does not influence patient survival after resection of colorectal cancer.
Molland G; Dent OF; Chapuis PH; Bokey EL; Nicholls M; Newland RC
Aust N Z J Surg; 1995 Aug; 65(8):592-5. PubMed ID: 7661803
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
44. A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.
Dorajoo SR; Tan WJ; Koo SX; Tan WS; Chew MH; Tang CL; Wee HL; Yap CW
Int J Colorectal Dis; 2016 Feb; 31(2):235-45. PubMed ID: 26490055
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
46. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial.
Harlaar JJ; Gosselink MP; Hop WC; Lange JF; Busch OR; Jeekel H
Ann Surg; 2012 Nov; 256(5):681-6; discussion 686-7. PubMed ID: 23095610
[TBL] [Abstract][Full Text] [Related]
47. Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.
Sheehan KM; O'Donovan DG; Fitzmaurice G; O'Grady A; O'Donoghue DP; Sheahan K; Byrne MF; Conroy RM; Kay EW; Murray FE
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):375-80. PubMed ID: 12655257
[TBL] [Abstract][Full Text] [Related]
48. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
J Pathol; 1997 Jul; 182(3):318-24. PubMed ID: 9349235
[TBL] [Abstract][Full Text] [Related]
50. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
[TBL] [Abstract][Full Text] [Related]
51. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
[TBL] [Abstract][Full Text] [Related]
52. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging?
Cianchi F; Messerini L; Palomba A; Boddi V; Perigli G; Pucciani F; Bechi P; Cortesini C
Dis Colon Rectum; 1997 Oct; 40(10):1170-5; discussion 1175-6. PubMed ID: 9336111
[TBL] [Abstract][Full Text] [Related]
53. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
Michel P; Paresy M; Lepessot F; Hellot MF; Paillot B; Scotte M; Peillon C; Ducrotté P; Hemet J
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):275-80. PubMed ID: 10750646
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of mucinous component in colorectal carcinoma.
Papadopoulos VN; Michalopoulos A; Netta S; Basdanis G; Paramythiotis D; Zatagias A; Berovalis P; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s123-5. PubMed ID: 15655594
[TBL] [Abstract][Full Text] [Related]
55. [Study on the prognostic factors of colorectal cancer after radical resection and on suggested model for prediction].
Yang YF; Li PZ; Liang XB; Han XL; Li YP; Cong J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):214-7. PubMed ID: 15941514
[TBL] [Abstract][Full Text] [Related]
56. Serum albumin: a prognostic indicator in patients with colorectal cancer.
Heys SD; Walker LG; Deehan DJ; Eremin OE
J R Coll Surg Edinb; 1998 Jun; 43(3):163-8. PubMed ID: 9654876
[TBL] [Abstract][Full Text] [Related]
57. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators.
Heimann TM; Oh SC; Martinelli G; Szporn A; Luppescu N; Lembo CA; Kurtz RJ; Fasy TM; Greenstein AJ
Am J Surg; 1992 Jul; 164(1):13-7. PubMed ID: 1626600
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of inferior mesenteric artery lymph node metastasis in cancer of the descending colon, sigmoid colon and rectum.
Rao X; Zhang J; Liu T; Wu Y; Jiang Y; Wang P; Chen G; Pan Y; Wu T; Liu Y; Wan Y; Huang S; Wang X
Colorectal Dis; 2018 Jun; 20(6):O135-O142. PubMed ID: 29577541
[TBL] [Abstract][Full Text] [Related]
59. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer.
De Angelis PM; Stokke T; Beigi M; Mjåland O; Clausen OP
Int J Colorectal Dis; 2001 Feb; 16(1):38-45. PubMed ID: 11317696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
